PharmEasy, once valued at over $5 billion, seeks new funding at a 90% valuation cut
Indian online pharmacy startup PharmEasy has informed its existing investors that it plans to raise a new round of funding via rights issue at a 90% markdown from the previous valuation, a person familiar with the matter said. PharmEasy, which earlier deferred a plan to go public, is racing to raise the new capital to…